Miltefosine--the long-awaited therapy for visceral leishmaniasis?

N Engl J Med. 1999 Dec 9;341(24):1840-2. doi: 10.1056/NEJM199912093412411.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Administration, Oral
  • Antiprotozoal Agents / adverse effects
  • Antiprotozoal Agents / therapeutic use*
  • Female
  • Gastrointestinal Diseases / chemically induced
  • Humans
  • Leishmaniasis, Visceral / drug therapy*
  • Phosphorylcholine / adverse effects
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / therapeutic use

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine